Neumora Therapeutics Depression Treatment Fails
This is a news story, published by Investor's Business Daily, that relates primarily to Neumora Therapeutics news.
Neumora Therapeutics news
For more Neumora Therapeutics news, you can click here:
more Neumora Therapeutics newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsInvestor's Business Daily news
For more news from Investor's Business Daily, you can click here:
more news from Investor's Business DailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Neumora Therapeutics stock. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest experimental depression treatment news, Asberg Depression Rating Scale news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Neumora TherapeuticsInvestor's Business Daily
•Neumora Therapeutics stock crashes 83.2% after depression treatment fails
74% Informative
Neumora Therapeutics stock crashed 83.2% to 1.78% in premarket trading.
The company's drug showed no difference from a placebo in treating depression symptoms.
The results were "very surprising given the prior data from them and JNJ ," RBC Capital Markets analyst Brian Abrahams said.
VR Score
76
Informative language
82
Neutral language
19
Article tone
formal
Language
English
Language complexity
48
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
2
Affiliate links
no affiliate links